Assembling intelligence…
IGF::OT::IGF PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| THE MEDICAL COLLEGE OF WISCONSIN, INC. | 8 | $3.9M | 2020-07-16 |
| HHSN26100006 THE MEDICAL COLLEGE OF WISCONSIN, INC. · National Institutes of Health | $800K | 2020-05-31 |
| HHSN26100002 THE MEDICAL COLLEGE OF WISCONSIN, INC. · National Institutes of Health | $633K | 2019-03-23 |
| HHSN26100004 THE MEDICAL COLLEGE OF WISCONSIN, INC. · National Institutes of Health | $629K | 2019-05-09 |
| HHSN26100003 THE MEDICAL COLLEGE OF WISCONSIN, INC. · National Institutes of Health | $599K | 2018-12-07 |
| 75N91018F00008 THE MEDICAL COLLEGE OF WISCONSIN, INC. · National Institutes of Health | $461K | 2020-07-16 |